Kliniken und Institute


Institut für Klinische Pharmakologie


Brockmöller

Leitung

Direktor
Prof. Dr. Jürgen Brockmöller

Sekretariat

Telefon: +49 (0) 551 39-53 11
Fax: +49 (0) 551 39-12 767
E-Mail: s.mueller@med.uni-goettingen.de

Anschrift

Robert-Koch-Str. 40
37075 Göttingen

Briefpostadresse

37099 Göttingen

Homepage

URL / Homepage www.klinpharm.med.uni-goettingen.de/

Downloads

PDF Publikationen 2014 2013 2012 2011 2010

2008

Ausgewählte Publikationen
  • Stingl Kirchheiner JC, Brockmöller J (2011)
    Why, when, and how should pharmacogenetics be applied in clinical studies?: current and future approaches to study designs. CLIN PHARMACOL THER, 89: 198-209.
  • Tzvetkov MV, Saadatmand AR, Lötsch J, Tegeder I, Stingl JC, Brockmöller J (2011)
    Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol. CLIN PHARMACOL THER, 90: 143-50.
  • Hoffmann M, Schirmer MA, Tzvetkov MV, Kreuz M, Ziepert M, Wojnowski L, Kube D, Pfreundschuh M, Trümper L, Loeffler M, Brockmöller J (2010)
    A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma. CANCER RES, 70: 2328-38.
  • Sachse-Seeboth C, Pfeil J, Sehrt D, Meineke I, Tzvetkov M, Bruns E, Poser W, Vormfelde SV, Brockmöller J (2009)
    Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9. CLIN PHARMACOL THER, 85: 273-6.
  • Vormfelde SV, Brockmöller J, Bauer S, Herchenhein P, Kuon J, Meineke I, Roots I, Kirchheiner J (2009)
    Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteers. CLIN PHARMACOL THER, 86: 54-61.

Suchworte: Arzneimittelforschung, Pharmakogenetik, Pharmakogenomik, Pharmakoepidemiologie, Arzneimittel-Nebenwirkungen, Therapeutisches Drug-Monitoring, Pharmakokinetik, Klinische Forschung, Arzneimittel